Please check your internet connection and try again.
## Ecospirin (Aspirin Enteric-Coated)
**Overview**
Ecospirin is an enteric-coated formulation of aspirin, a nonsteroidal anti-inflammatory drug (NSAID) that acts as an antiplatelet agent. The enteric coating is designed to prevent dissolution in the stomach, reducing gastric irritation.
**Primary Indications**
* Prevention of cardiovascular events (myocardial infarction, stroke) in patients with established cardiovascular disease or risk factors.
* Adjunctive therapy in certain acute cardiovascular conditions.
**Adult Dosing**
* **Cardiovascular Prevention:** Typically 75 mg to 162 mg once daily. Specific dosing may vary based on local guidelines and patient risk stratification. Some guidelines suggest higher doses (e.g., 325 mg) for acute events.
* **Maximum Dose:** Not typically applicable for chronic prevention. For acute indications, doses may be higher but should follow specific protocols.
**Pediatric Dosing**
Aspirin is generally **not recommended** in children and adolescents for fever or viral infections due to the risk of Reye's syndrome. If indicated for specific conditions like Kawasaki disease, dosing is weight-based and should be determined by a specialist according to established protocols.
**Dose Adjustments**
* **Renal Impairment:** Use with caution. Dose adjustments may be necessary in severe renal impairment.
* **Hepatic Impairment:** Use with caution.
**Contraindications**
* Hypersensitivity to aspirin, salicylates, or NSAIDs.
* Active peptic ulceration or gastrointestinal bleeding.
* History of aspirin-induced asthma or urticaria.
* Bleeding disorders.
* Severe hepatic or renal impairment.
* In children and adolescents with viral infections (risk of Reye's syndrome).
**Adverse Effects**
* **Gastrointestinal:** Dyspepsia, nausea, vomiting, abdominal pain, erosions, ulcers, bleeding.
* **Hematologic:** Increased bleeding risk, bruising, petechiae, epistaxis.
* **Hypersensitivity:** Bronchospasm, urticaria, angioedema.
* **Other:** Tinnitus, dizziness, headache.
**Key Drug Interactions**
* **Anticoagulants (e.g., warfarin, DOACs), other antiplatelets (e.g., clopidogrel), and SNRIs:** Increased risk of bleeding.
* **NSAIDs (including COX-2 inhibitors):** Increased risk of gastrointestinal toxicity and potential reduction in cardioprotective effects of low-dose aspirin.
* **Corticosteroids:** Increased risk of gastrointestinal ulceration and bleeding.
* **Methotrexate:** Increased methotrexate toxicity.
* **Uricosuric agents (e.g., probenecid):** Reduced efficacy of uricosuric agents.
* **Alcohol:** Increased risk of gastrointestinal bleeding.
**Monitoring**
* Signs and symptoms of gastrointestinal bleeding (e.g., melena, hematemesis, abdominal pain).
* Signs and symptoms of bleeding elsewhere (e.g., bruising, epistaxis).
* Renal and hepatic function, especially with long-term use or in patients with pre-existing organ dysfunction.
**Clinical Pearls**
* Enteric coating delays absorption and reduces gastric irritation but does not eliminate the risk of GI bleeding.
* Should be swallowed whole; do not crush, chew, or break.
* The cardioprotective benefit of low-dose aspirin outweighs the risks in most appropriate patients.
* Discontinue aspirin at least 5-7 days prior to elective surgery, if possible, after considering the risk of thrombotic events.
***
**Disclaimer:** This information is intended for healthcare professionals. Always consult the official prescribing information and relevant clinical guidelines for complete details and to ensure patient safety.
